IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Biomark Capital Management Co. LLC

Q4 2016 Holdings

Filed 2017-02-13 | 3 holdings | $7.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Adma Biologics, Inc.(ADMA)COM000899104$7.3M1,433,30499.4%
Juno Therapeutics, Inc.COM48205A109$40.9K2,168,6010.6%
Mabvax Therapeutics Holdings, Inc.COM NEW55414P504$9026,7080.0%